Related references
Note: Only part of the references are listed.Induction of mucosal immunity and protection by intranasal immunization with a respiratory syncytial virus subunit vaccine formulation
R. Garg et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity
C. Trumpfheller et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Long-Term and Memory Immune Responses in Mice against Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus Glycoprotein Ectodomains
Madelyn R. Schmidt et al.
JOURNAL OF VIROLOGY (2012)
Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles
S. Garlapati et al.
VACCINE (2012)
Mucosal vaccination: Lung versus nose
Ana Vujanic et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2012)
Double-stranded RNA induces similar pulmonary dysfunction to respiratory syncytial virus in BALB/c mice
Famke Aeffner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Multifunctional cationic host defence peptides and their clinical applications
Amy T. Y. Yeung et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
Barney S. Graham
IMMUNOLOGICAL REVIEWS (2011)
Understand memory, design better vaccines
Michael J. Bevan
NATURE IMMUNOLOGY (2011)
Immunological mechanisms of vaccination
Bali Pulendran et al.
NATURE IMMUNOLOGY (2011)
Activation of Interferon Response Through Toll-Like Receptor 3 Impacts Viral Pathogenesis and Pulmonary Toll-Like Receptor Expression During Respiratory Syncytial Virus and Influenza Infections in the Cotton Rat Sigmodon hispidus Model
Marina S. Boukhvalova et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Intranasal Administration of Adjuvant-Combined Vaccine Protects Monkeys From Challenge With the Highly Pathogenic Influenza A H5N1 Virus
Takeshi Ichinohe et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)
Nicholas Butowski et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
Maria Florencia Delgado et al.
NATURE MEDICINE (2009)
Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization
Alexander K. Andrianov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice
J. Kovacs-Nolan et al.
VACCINE (2009)
A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel® + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults
Issaka Sagara et al.
VACCINE (2009)
Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques
Christiane Stahl-Hennig et al.
PLOS PATHOGENS (2009)
Long-term activation of TLR3 by Poly(I:C) induces inflammation and impairs lung function in mice
Nicole C. Stowell et al.
RESPIRATORY RESEARCH (2009)
TLR3:: Interferon induction by double-stranded RNA including poly(I:C)
Misako Matsumoto et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years
C. L. Cooper et al.
CLINICAL INFECTIOUS DISEASES (2008)
Respiratory syncytial virus (RSV) vaccines - Two steps back for one leap forward
Ultan F. Power
JOURNAL OF CLINICAL VIROLOGY (2008)
Intranasal immunization of mice with a formal in-inactivated bovine respiratory syncytial virus vaccine co-formulated with CpG oligodeoxynucleotides and polyphosphazenes results in enhanced protection
John W. Mapletoft et al.
JOURNAL OF GENERAL VIROLOGY (2008)
The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine
Christine Trumpfheller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Viral and host factors in human respiratory syncytial virus pathogenesis
Peter L. Collins et al.
JOURNAL OF VIROLOGY (2008)
The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response
Antoine Minne et al.
IMMUNOLOGY (2007)
Human infant respiratory syncytial virus (RSV)-specific type 1 and 2 cytokine responses ex vivo during primary RSV infection
F. Eun-Hyung Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses
Timothy P. Welliver et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
The histopathology of fatal untreated human respiratory syncytial virus infection
Joyce E. Johnson et al.
MODERN PATHOLOGY (2007)
Intranasal immunization with H5N1 vaccine plus Poly I : Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge
Takeshi Ichinohe et al.
MICROBES AND INFECTION (2007)
Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide
Neeloffer Mookherjee et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Direct stimulation of T cells by type IIFN enhances the CD8+ T cell response during cross-priming
Agnes Le Bon et al.
JOURNAL OF IMMUNOLOGY (2006)
Respiratory syncytial virus infection in elderly and high-risk adults
AR Falsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection
T Ichinohe et al.
JOURNAL OF VIROLOGY (2005)
Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine
CL Cooper et al.
VACCINE (2004)
Genetically programmed B lymphocytes are highly efficient in inducing anti-virus protective immunity mediated by central memory CD8 T cells
P Castiglioni et al.
VACCINE (2004)
Lineage relationship and protective immunity of memory CD8 T cell subsets
EJ Wherry et al.
NATURE IMMUNOLOGY (2003)
Immunoprotective activity and safety of a respiratory syncytial virus vaccine: Mucosal delivery of fusion glycoprotein with a CpG oligodeoxynucleotide adjuvant
GA Prince et al.
JOURNAL OF VIROLOGY (2003)
Plasmacytoid dendritic cells: The key to CpG
S Rothenfusser et al.
HUMAN IMMUNOLOGY (2002)
CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein
XP Ioannou et al.
VACCINE (2002)
Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides
V Hornung et al.
JOURNAL OF IMMUNOLOGY (2002)
Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia
DS Southam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
Antigen-specific CD8+ T cells persist in the upper respiratory tract following influenza virus infection
JA Wiley et al.
JOURNAL OF IMMUNOLOGY (2001)
CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV)
GE Hancock et al.
VACCINE (2001)
Medical progress - Respiratory syncytial virus and parainfluenza virus.
CB Hall
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
